CEO Steven Basta told attendees at the Guggenheim Emerging Outlook Biotech Summit 2026 that the company’s commercial focus over the past year has shifted more heavily toward gastroenterology, a move h ...
The actor/model scores 17 points as Team Giannis beats Team Anthony, 65-58, in a game that brought basketball back to the ...
In a game that featured a 7-foot-6 giant overwhelming everything in sight, the MVP trophy somehow ended up in the hands of a ...
Maze Therapeutics (NASDAQ:MAZE) is advancing a genetics-driven approach to drug development, using human genetic analyses to identify gene variants linked to disease and then applying those insights ...
Normally, books with reviews that bad are ignored by the big money in TV — however, Peacock, desperate to tap into Americans’ obsession with the royal soap opera, optioned the book even before it was ...
Weeks after Nigel Havers completed another lucrative pantomime run at the London Palladium, his grumpy former agent Michael Whitehall takes unflattering aim. Despite his friendship with the actor ...
Banking apps, snack foods, streaming hits, and data tools are all part of Jimmy Donaldson’s growing $5 billion portfolio under Beast Industries.
ITV’s The Summit has big personalities, mountain drama and a surprise appearance from Afton McKeith. But is it enough to reach the top in ...
Ian Hyland reviews ITV’s The Summit and argues a late twist can’t rescue a slow, derivative reality show hosted by Ben ...
The premise is simple: an unlikable group of strangers try to climb one of the New Zealand Alps, despite being vastly unsuited to it. I despise the show, the contestants, and myself for watching it ...
Eat Sleep Cruise on MSN
This Celebrity Summit cruise was not the premium experience we expected
Celebrity Cruises has a reputation for premium cruising — but this Celebrity Summit trip didn’t match expectations. This review breaks down what surprised passengers the most, from the onboard ...
Summit Therapeutics (SMMT) added ~5% in the premarket on Thursday after the company announced that the U.S. FDA accepted its Biologics License Application (BLA) for its lead asset ivonescimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results